Found: 53
Select item for more details and to access through your institution.
Differences of vascular endothelial growth factor (VEGF) expression between liver and abdominal metastases from colon cancer. Implications for the treatment with VEGF inhibitors.
- Published in:
- Clinical & Experimental Metastasis, 2000, v. 18, n. 8, p. 651, doi. 10.1023/A:1013133224044
- By:
- Publication type:
- Article
Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 5, p. 1313, doi. 10.1007/s00520-012-1667-5
- By:
- Publication type:
- Article
Erratum to: Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV.
- Published in:
- 2013
- By:
- Publication type:
- Correction notice
Adalimumab Biosimilar in Pediatric Inflammatory Bowel Disease: A Retrospective Study from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD).
- Published in:
- Healthcare (2227-9032), 2024, v. 12, n. 3, p. 404, doi. 10.3390/healthcare12030404
- By:
- Publication type:
- Article
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep06828
- By:
- Publication type:
- Article
Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer.
- Published in:
- Oncogene, 2002, v. 21, n. 53, p. 8192, doi. 10.1038/sj.onc.1205921
- By:
- Publication type:
- Article
Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 3, p. 628, doi. 10.1002/ijc.21397
- By:
- Publication type:
- Article
Association of thymidylate synthase polymorphisms with gastric cancer susceptibility.
- Published in:
- International Journal of Cancer, 2004, v. 112, n. 6, p. 1010, doi. 10.1002/ijc.20489
- By:
- Publication type:
- Article
Preliminary Evaluation of Plasmix Compound from Plastics Packaging Waste for Reuse in Bituminous Pavements.
- Published in:
- Sustainability (2071-1050), 2021, v. 13, n. 4, p. 2258, doi. 10.3390/su13042258
- By:
- Publication type:
- Article
VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population.
- Published in:
- International Journal of Colorectal Disease, 2009, v. 24, n. 2, p. 165, doi. 10.1007/s00384-008-0586-x
- By:
- Publication type:
- Article
Expression of p53 as a biomarker of pazopanib efficacy in solitary fibrous tumours: translational analysis of a phase II trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221116155
- By:
- Publication type:
- Article
Inhaled nitric oxide as a rescue therapy in a preterm neonate with severe pulmonary hypertension: a case report.
- Published in:
- Italian Journal of Pediatrics, 2018, v. 44, n. 1, p. N.PAG, doi. 10.1186/s13052-018-0494-9
- By:
- Publication type:
- Article
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 6, p. 1064, doi. 10.1007/s10120-020-01078-0
- By:
- Publication type:
- Article
A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases.
- Published in:
- Gastric Cancer, 2013, v. 16, n. 3, p. 411, doi. 10.1007/s10120-012-0204-z
- By:
- Publication type:
- Article
Sequential chemotherapy with cisplatin, leucovorin, and 5-fluorouracil followed by docetaxel in previously untreated patients with metastatic gastric cancer: a phase II study.
- Published in:
- Gastric Cancer, 2012, v. 15, n. 4, p. 419, doi. 10.1007/s10120-011-0134-1
- By:
- Publication type:
- Article
Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients.
- Published in:
- Oncology, 2016, v. 91, n. 5, p. 283, doi. 10.1159/000448004
- By:
- Publication type:
- Article
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients.
- Published in:
- Oncology, 2012, v. 82, n. 2, p. 75, doi. 10.1159/000329079
- By:
- Publication type:
- Article
Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working Group.
- Published in:
- Pediatric Drugs, 2022, v. 24, n. 1, p. 57, doi. 10.1007/s40272-021-00486-8
- By:
- Publication type:
- Article
High safety profile and activity of oral vinorelbine in an elderly patient with metastatic breast cancer.
- Published in:
- Breast Cancer (13406868), 2012, v. 19, n. 3, p. 275, doi. 10.1007/s12282-009-0156-2
- By:
- Publication type:
- Article
Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 2, p. 493, doi. 10.1007/s00432-019-03077-w
- By:
- Publication type:
- Article
High Let-7a MicroRNA Levels in KRAS-Mutated Colorectal Carcinomas May Rescue Anti-EGFR Therapy Effects in Patients with Chemotherapy-Refractory Metastatic Disease.
- Published in:
- Oncologist, 2012, v. 17, n. 6, p. 823, doi. 10.1634/theoncologist.2012-0081
- By:
- Publication type:
- Article
High Concordance of KRAS Status Between Primary Colorectal Tumors and Related Metastatic Sites: Implications for Clinical Practice.
- Published in:
- Oncologist, 2008, v. 13, n. 12, p. 1270, doi. 10.1634/theoncologist.2008-0181
- By:
- Publication type:
- Article
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-47627-1
- By:
- Publication type:
- Article
Prospective Validation of Candidate SNPs of <i>VEGF/VEGFR</i> Pathway in Metastatic Colorectal Cancer Patients Treated with First-Line FOLFIRI Plus Bevacizumab.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0066774
- By:
- Publication type:
- Article
SPOSAB ABP 501: A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 11, p. 3041, doi. 10.1111/jgh.15590
- By:
- Publication type:
- Article
MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Meta- and Pooled Analyses of the Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Gastric Cancer Risk: A Huge-GSEC Review.
- Published in:
- American Journal of Epidemiology, 2008, v. 167, n. 5, p. 505
- By:
- Publication type:
- Article
Prevalence of delivery mode in an Italian nationwide cohort with celiac disease: a SIGENP multicenter retrospective study (the CD-deliver-IT).
- Published in:
- Italian Journal of Pediatrics, 2024, v. 50, n. 1, p. 1, doi. 10.1186/s13052-024-01710-0
- By:
- Publication type:
- Article
Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 438, doi. 10.1186/1471-2407-14-357
- By:
- Publication type:
- Article
Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-357
- By:
- Publication type:
- Article
Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer.
- Published in:
- BMC Cancer, 2011, v. 11, n. 1, p. 247, doi. 10.1186/1471-2407-11-247
- By:
- Publication type:
- Article
A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: a case control study in an Italian population.
- Published in:
- 2008
- By:
- Publication type:
- journal article
A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: A case control study in an Italian population.
- Published in:
- BMC Cancer, 2008, v. 8, p. 1, doi. 10.1186/1471-2407-8-138
- By:
- Publication type:
- Article
Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Novel germline CDH1 mutations in hereditary diffuse gastric cancer families.
- Published in:
- Human Mutation, 2002, v. 19, n. 5, p. 518, doi. 10.1002/humu.10067
- By:
- Publication type:
- Article
Impact of Signet-Ring Cell Histology in the Management of Patients with Non-Metastatic Gastric Cancer: Results from a Retrospective Multicenter Analysis Comparing FLOT Perioperative Chemotherapy vs. Surgery Followed by Adjuvant Chemotherapy.
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3342, doi. 10.3390/cancers15133342
- By:
- Publication type:
- Article
TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2049, doi. 10.3390/cancers12082049
- By:
- Publication type:
- Article
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients.
- Published in:
- Journal of Cellular & Molecular Medicine, 2013, v. 17, n. 11, p. 1415, doi. 10.1111/jcmm.12109
- By:
- Publication type:
- Article
PML as a potential predictive factor of oxaliplatin/fluoropyrimidine-based first line chemotherapy efficacy in colorectal cancer patients.
- Published in:
- Journal of Cellular Physiology, 2012, v. 227, n. 3, p. 927, doi. 10.1002/jcp.22801
- By:
- Publication type:
- Article
Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer.
- Published in:
- Journal of Cellular Physiology, 2010, v. 223, n. 2, p. 384, doi. 10.1002/jcp.22045
- By:
- Publication type:
- Article
Metronomic Oral Vinorelbine: An Alternative Schedule in Elderly and Patients PS2 With Local/Advanced and Metastatic NSCLC Not Oncogene-addicted.
- Published in:
- In Vivo, 2020, v. 34, n. 5, p. 2687, doi. 10.21873/invivo.12088
- By:
- Publication type:
- Article
Association of Immune Thrombocytopenia and Inflammatory Bowel Disease in Children.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 9, p. 1940, doi. 10.3390/jcm10091940
- By:
- Publication type:
- Article
Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2007, v. 45, n. 7, p. 822, doi. 10.1515/CCLM.2007.143
- By:
- Publication type:
- Article
A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Consolidation biochemotherapy for patients with advanced nonsmall cell lung carcinoma responding to induction PVM (cisplatin, vinblastine, mitomycin-C) regimen: A phase II study.
- Published in:
- Cancer (0008543X), 1996, v. 77, n. 11, p. 2251, doi. 10.1002/(SICI)1097-0142(19960601)77:11<2251::AID-CNCR11>3.0.CO;2-W
- By:
- Publication type:
- Article
Rescue Therapy with Intensive Vedolizumab Optimization in a Seventeen-Year-Old Girl with Acute Severe Ulcerative Colitis.
- Published in:
- 2021
- By:
- Publication type:
- Letter
HtrA1, a potential predictor of response to cisplatin-based combination chemotherapy in gastric cancer.
- Published in:
- Histopathology, 2011, v. 58, n. 5, p. 669, doi. 10.1111/j.1365-2559.2011.03818.x
- By:
- Publication type:
- Article
Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial.
- Published in:
- 2010
- By:
- Publication type:
- journal article